Pentasure Nutrition

Mumbai, India Founded: 1993 • Age: 33 yrs Listed
Provides comprehensive clinical nutrition solutions and a range of nutritional products.
Request Access
Report Incorrect Data
Page last updated

About Pentasure Nutrition

Pentasure Nutrition is a publicly listed company based in Mumbai (India) founded in 1993. It provides comprehensive clinical nutrition solutions and a range of nutritional products. It operates on a B2B model. The company has 264 employees. Its Indian entity Hexagon Nutrition Limited reported revenue of ₹395 Cr. Its focus areas include Medical Nutrition, Clinical Nutrition and Product Distribution. Its competitors include Plix, OZiva and Wellbeing Nutrition; 3 of its 3 listed competitors have raised funding.

Company details

Pentasure Nutrition, based in Mumbai, focuses on providing healthcare solutions, medical nutrition, clinical nutrition, and product distribution. Provides comprehensive clinical nutrition solutions and a range of nutritional products. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Operational Areas
Healthcare → Pharmaceuticals & Distribution
Key Metrics
  • Market Cap
    ₹710 Cr

    HEXAGON · NSE

  • Share Price
    ₹56.59

    -1.97% today

  • Revenue
    ₹383 Cr

    FY 2025-26 · +17.8% YoY

  • EBITDA
    ₹52.60 Cr

    Margin 13.8%

  • Net Profit
    ₹35.55 Cr

    FY 2025-26 · +52.8% YoY

  • P/E (TTM)
    18.9x

    P/B 2.6x

  • ROE
    17.8%

    ROCE 22.1%

  • Debt / Equity
    0.14

    Interest cover 9.4x

  • Employee Count
    264

Apps and channels of Pentasure Nutrition

its YouTube channel Pentasure Nutrition has 116 subscribers and 19 videos.

Pentasure Nutrition
YouTube 116 subscribers 19 videos Howto & Style
Open channel

Videos from Pentasure Nutrition

The most watched videos on Pentasure Nutrition's YouTube channel, Pentasure Nutrition (116 subscribers). Click a video to play it here.

Pentasure DM - Diabetes care | Optimal nutrition for managing diabetes | Your ultimate solution
4.5K views
Pentasure 2.0 : The BEST Supplement for Healthy Weight Gain! 💪🔥
1.2K views
Pentasure Complete Balance Nutrition: A Perfect Solution for Your Daily Health Needs
839 views
PentaSure DM: All-In-One Nutritional Powerhouse for Strength and Health With Diabetes Care!!!
675 views

More on Pentasure Nutrition.

Board of directors of Hexagon Nutrition Limited (Pentasure Nutrition)

Hexagon Nutrition Limited is the primary company behind Pentasure Nutrition. The board of Hexagon Nutrition Limited currently have 8 directors; the longest-serving is Vikram Arun Kelkar, appointed in 2005. 25 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vikram Arun Kelkar
DIN 02302364
Managing Director01 Sep 200521 yrs 1 moHexagon Nutrition Limited
Nikhil Arun Kelkar
DIN 02302369
Managing Director21 Aug 200818 yrs 2 moHexagon Nutrition Limited
Aparna Deepak Sakpal
DIN 10345258
Director31 Oct 20232 yrs 11 moHexagon Nutrition Limited
Meena Bipinchandra Mehta
DIN 10974239
Director05 Mar 20251 yr 7 moHexagon Nutrition Limited
Nimesh Pratap Shukla
DIN 10974257
Director05 Mar 20251 yr 7 moHexagon Nutrition Limited
Keval Mahendra Shah
DIN 07649694
Director20 May 20251 yr 5 moHexagon Nutrition Limited
Payal Yash Gaglani
DIN 08546549
Director20 May 20251 yr 5 moHexagon Nutrition Limited
Raghunath Dattaram Sawant
DIN 11863172
Director12 Aug 20262 moHexagon Nutrition Limited

IPO & Listings of Pentasure Nutrition

Pentasure Nutrition is a publicly listed company on the NSE with ticker symbol HEXAGON in India. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: HEXAGON
  • Listed entityHexagon Nutrition Limited

Financials of Pentasure Nutrition

Exchange-reported figures of Hexagon Nutrition Limited, the listed company behind Pentasure Nutrition (NSE: HEXAGON).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹383 Cr
+17.8% YoY
EBITDA
₹52.60 Cr
+31.6% YoY
Profit After Tax
₹35.55 Cr
+52.8% YoY
Net Worth
₹233 Cr
+20.1% YoY
Total Assets
₹272 Cr
+19.1% YoY
Total Debt
₹32.70 Cr
+13.8% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2021-22FY 2020-21
Income statement
Revenue383325298271211
Revenue growth+17.8%+9.1%-+28.1%-
EBITDA52.6039.9724.5036.2333.98
EBITDA margin+13.8%+12.3%+8.2%+13.4%+16.1%
Profit before tax51.1833.6919.5032.4431.14
Net profit35.5523.2711.6022.2421.09
Net profit margin+9.3%+7.2%+3.9%+8.2%+10.0%
EPS (₹)3.432.201.102.112.07
Balance sheet
Total assets272228219206163
Net worth233194176160138
Total debt32.7028.7336.8939.9620.27
Cash & bank17.9320.0223.9028.0922.00
Net working capital15811712811889.38
Cash flow
Cash from operations6.2338.4723.3811.3828.56
Cash from investing(5.26)(23.35)3.71(21.23)(9.28)
Cash from financing(0.42)(19.26)(19.13)15.56(17.81)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
Revenue10411599.5495.1872.86107
Revenue growth (YoY)+43.2%+8.0%----
Other income2.144.252.294.321.391.24
EBITDA11.7415.0515.2512.2410.0412.10
EBITDA margin+11.3%+13.1%+15.3%+12.9%+13.8%+11.4%
Depreciation2.302.752.492.242.172.30
Interest0.981.131.110.990.801.01
Profit before tax10.6015.4213.9413.338.4610.03
Tax2.534.533.513.202.012.27
Net profit8.0710.8910.4310.136.457.76
EPS (₹)0.660.890.850.000.530.63
MetricsFY 2025-26FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue31913211410787.1098.86
Revenue growth-+15.9%+6.9%+22.6%-11.9%-
EBITDA43.3012.72(4.57)12.847.369.32
EBITDA margin+13.6%+9.6%-4.0%+12.0%+8.5%+9.4%
Profit before tax51.2513.97(2.63)12.607.487.93
Net profit37.9010.480.738.064.638.23
Net profit margin+11.9%+7.9%+0.6%+7.6%+5.3%+8.3%
EPS (₹)3.100.95(0.28)0.810.510.67
Balance sheet
Total assets26211692.2892.2174.6374.33
Net worth23172.5461.9167.3759.9858.31
Total debt24.9640.2227.6222.0912.3814.11
Cash & bank10.334.905.524.736.836.60
Net working capital17742.5051.4547.6529.8339.22
Cash flow
Cash from operations8.36(2.25)7.160.835.0010.17
Cash from investing(19.77)(8.03)(8.17)(10.66)(1.77)(0.77)
Cash from financing10.5111.152.567.16(4.50)(4.81)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
Revenue10198.4781.8975.5063.2683.45
Revenue growth (YoY)+60.3%+18.0%----
Other income3.036.473.003.972.122.22
Total expenses89.0984.4769.6066.1055.6574.89
EBITDA12.3114.0012.299.407.618.56
EBITDA margin+12.1%+14.2%+15.0%+12.5%+12.0%+10.3%
Depreciation1.431.651.441.321.341.35
Interest0.670.620.440.420.400.52
Profit before tax13.2418.2013.4111.637.998.91
Tax3.404.563.542.972.022.28

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 28 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
Revenue10411599.5495.1872.86107
Revenue growth (YoY)+43.2%+8.0%----
Other income2.144.252.294.321.391.24
EBITDA11.7415.0515.2512.2410.0412.10
EBITDA margin+11.3%+13.1%+15.3%+12.9%+13.8%+11.4%
Depreciation2.302.752.492.242.172.30
Interest0.981.131.110.990.801.01
Profit before tax10.6015.4213.9413.338.4610.03
Tax2.534.533.513.202.012.27
Net profit8.0710.8910.4310.136.457.76
EPS (₹)0.660.890.850.000.530.63
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2021-22FY 2020-21
Revenue383325298271211
Revenue growth+17.8%+9.1%-+28.1%-
Other income12.246.447.275.195.88
Total expenses330285273235178
Employee cost50.4441.9139.6936.3630.80
EBITDA52.6039.9724.5036.2333.98
EBITDA margin+13.8%+12.3%+8.2%+13.4%+16.1%
Depreciation9.648.778.126.686.14
Interest4.023.954.152.302.58
Profit before tax51.1833.6919.5032.4431.14
Tax13.249.417.299.148.29
Net profit35.5523.2711.6022.2421.09
Net profit margin+9.3%+7.2%+3.9%+8.2%+10.0%
EPS (₹)3.432.201.102.112.07
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2021-22FY 2020-21
Equity & liabilities
Share capital11.0611.0623.2711.0511.05
Reserves & surplus222183153149127
Shareholders' funds (net worth)233194176160138
Minority interest0.000.000.000.000.00
Secured loans30.3126.6036.8939.9420.27
Unsecured loans2.392.130.000.020.00
Total debt32.7028.7336.8939.9620.27
Total liabilities272228219206163
Assets
Gross block14213312610695.69
Net block63.9064.2565.0754.9550.72
Capital work in progress2.534.052.406.831.15
Investments37.4133.9518.9922.8018.05
Inventories83.9061.2179.3860.6659.70
Sundry debtors81.7259.8248.5156.4740.46
Cash & bank balances17.9320.0223.9028.0922.00
Loans & advances20.439.147.9124.0017.66
Total current assets204150160169140
Total current liabilities46.4733.0231.5451.0650.44
Net working capital15811712811889.38
Total assets272228219206163
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2021-22FY 2020-21
Opening cash15.2219.3511.3917.5116.03
Net cash from operating activities6.2338.4723.3811.3828.56
Net cash from investing activities(5.26)(23.35)3.71(21.23)(9.28)
Net cash from financing activities(0.42)(19.26)(19.13)15.56(17.81)
Net change in cash0.55(4.13)7.975.711.48
Closing cash17.9320.0223.9028.0922.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2021-22FY 2020-21
Growth
Sales growth+17.8%+9.1%-+28.1%-
EBITDA growth+31.6%+63.1%-+6.6%-
PBT growth+51.9%+72.8%-39.9%+4.2%+9997.0%
Net income growth+52.8%+100.6%-+5.5%-
Revenue CAGR (3Y)+12.2%+15.4%---
EBITDA CAGR (3Y)+13.2%+5.6%---
Profitability & leverage
Net income margin+9.9%+7.5%+4.1%+8.6%+10.8%
Return on capital employed+22.1%+16.8%+10.8%+18.9%+21.2%
Return on net worth+17.8%+13.6%+7.5%+15.7%+18.0%
Debt / equity0.140.180.260.200.21
Long-term debt / equity0.040.050.040.030.07
Interest cover9.3612.6625.347.789.27
Efficiency & per share
Fixed asset turnover2.782.502.492.692.25
Inventory turnover5.274.623.574.503.71
Debtors turnover5.416.004.855.595.17
EPS (₹)3.432.201.102.112.07
Dividend per share (₹)0.000.000.000.000.00
Book value per share (₹)21.0917.5514.7914.4512.49
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
Revenue10198.4781.8975.5063.2683.45
Revenue growth (YoY)+60.3%+18.0%----
Other income3.036.473.003.972.122.22
Total expenses89.0984.4769.6066.1055.6574.89
EBITDA12.3114.0012.299.407.618.56
EBITDA margin+12.1%+14.2%+15.0%+12.5%+12.0%+10.3%
Depreciation1.431.651.441.321.341.35
Interest0.670.620.440.420.400.52
Profit before tax13.2418.2013.4111.637.998.91
Tax3.404.563.542.972.022.28
ParticularsFY 2025-26FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue31913211410787.1098.86
Revenue growth-+15.9%+6.9%+22.6%-11.9%-
Other income15.575.605.982.503.322.51
Total expenses27611911993.9079.7489.54
Employee cost0.0024.3325.9221.2718.2220.35
EBITDA43.3012.72(4.57)12.847.369.32
EBITDA margin+13.6%+9.6%-4.0%+12.0%+8.5%+9.4%
Depreciation5.742.902.652.022.182.75
Interest1.881.451.390.721.021.15
Profit before tax51.2513.97(2.63)12.607.487.93
Tax13.093.530.473.651.810.54
Net profit37.9010.480.738.064.638.23
Net profit margin+11.9%+7.9%+0.6%+7.6%+5.3%+8.3%
EPS (₹)3.100.95(0.28)0.810.510.67
ParticularsFY 2025-26FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital11.0611.0611.0611.0523.2623.26
Reserves & surplus22049.2738.6456.3236.7235.05
Shareholders' funds (net worth)23172.5461.9167.3759.9858.31
Secured loans26.6116.1227.6222.0912.3814.11
Unsecured loans(1.65)24.100.000.000.000.00
Total debt24.9640.2227.6222.0912.3814.11
Total liabilities26211692.2892.2174.6374.33
Assets
Gross block97.0650.3046.7343.7141.1944.15
Net block40.6624.5722.3920.4719.6621.40
Capital work in progress0.651.651.182.010.290.15
Investments33.927.8116.3619.5415.7612.17
Inventories66.1627.1626.9527.4618.7116.94
Sundry debtors77.9224.3523.6415.1813.4513.57
Cash & bank balances10.334.905.524.736.836.60
Loans & advances66.4911.2728.7623.799.9723.80
Total current assets22167.6884.8771.1648.9660.91
Total current liabilities43.7025.1833.4223.5119.1321.69
Net working capital17742.5051.4547.6529.8339.22
Total assets26211692.2892.2174.6374.33
ParticularsFY 2025-26FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash10.673.521.974.645.912.00
Net cash from operating activities8.36(2.25)7.160.835.0010.17
Net cash from investing activities(19.77)(8.03)(8.17)(10.66)(1.77)(0.77)
Net cash from financing activities10.5111.152.567.16(4.50)(4.81)
Net change in cash(0.91)0.881.55(2.68)(1.27)4.60
Closing cash10.334.905.524.736.836.60
ParticularsFY 2025-26FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-+15.9%+6.9%+22.6%-11.9%-
EBITDA growth-+378.3%-135.6%+74.5%-21.0%-
PBT growth+266.9%+9998.0%-+68.5%-5.7%+9997.0%
Net income growth-+1335.6%-90.9%+74.1%-43.7%-
Revenue CAGR (3Y)+44.1%+14.9%+4.9%---
EBITDA CAGR (3Y)+50.0%+20.0%----
Profitability & leverage
Net income margin+12.0%+7.9%-2.7%+8.4%+6.5%+7.5%
Return on capital employed-+14.8%+2.4%+14.4%+9.6%+14.3%
Return on net worth-+15.6%+1.1%+14.0%+9.9%+19.5%
Debt / equity-0.500.380.270.220.28
Long-term debt / equity-0.040.030.040.070.11
Interest cover5.0114.77-19.256.6519.6917.50
Efficiency & per share
Fixed asset turnover-2.722.522.512.042.24
Inventory turnover-4.894.194.624.896.10
Debtors turnover-5.515.887.466.455.46
EPS (₹)3.100.95(0.28)0.810.510.67
Dividend per share (₹)0.000.000.000.000.000.00
Book value per share (₹)0.005.454.496.104.324.17

Competitors of Pentasure Nutrition

Pentasure Nutrition has 3 listed competitors in our database, 3 of them funded. They include Plix, OZiva and Wellbeing Nutrition.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
Plix
plixlife.com2018Thane, India$11.1M217
Nutritional supplements are offered online by Plix using plant-based ingredients.
OZiva
oziva.in2010Mumbai, India$17.32M145
Nutritional food and health supplements are provided by OZiva.
Wellbeing Nutrition
wellbeingnutrition.com2019Mumbai, India$16.73M136
Organic whole-food nutritional supplements are provided for health benefits.
Premium access

Detailed competitors of Pentasure Nutrition

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pentasure Nutrition

$11 billion worth of IPO shares set for lock-in expiry over next 3 months. What shareholders should know - The Economic Times
Economic Times • 3 months ago
Hexagon Nutrition IPO: Last day to bid! Subscription crosses 20x so far; here's what investors should know
ZEE Business • 4 months ago
Hexagon Nutrition IPO Day 2: Public issue subscribed 4.2x so far; retail portion booked nearly 6 times
Moneycontrol • 4 months ago
Hexagon Nutrition raises ₹41.6 crore from anchor investors ahead of IPO | Stock Market News
mint • 4 months ago
Hexagon Nutrition raises Rs 41.66 crore from anchor investors ahead of IPO launch on June 5
ZEE Business • 4 months ago
Hexagon Nutrition IPO: 5 key things investors should know ahead of June 5 launch
ZEE Business • 4 months ago
Upcoming IPO: Hexagon Nutrition's public offer opens next week; check price band, lot size and key dates
ZEE Business • 5 months ago
Hexagon Nutrition IPO opens June 5: Price band fixed at Rs 42-45; check key details here - The Economic Times
Economic Times • 5 months ago
Particles for Humanity and Hexagon Nutrition Sign License Agreement
Prnewswire • 1 year ago
Healthcare-focused PE firm Somerset Indus Capital exits 9-year-old bet
Yourstory • 1 year ago
Premium access

Complete news archive for Pentasure Nutrition

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pentasure Nutrition

Pentasure Nutrition was founded in 1993.

Pentasure Nutrition is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Pentasure Nutrition has 264 employees.

The primary company behind Pentasure Nutrition, Hexagon Nutrition Limited, reported revenue of ₹395 Cr for FY 2026, up 18% year on year.

Pentasure Nutrition, based in Mumbai, focuses on providing healthcare solutions, medical nutrition, clinical nutrition, and product distribution. Provides comprehensive clinical nutrition solutions and a range of nutritional products. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Pentasure Nutrition's top competitors include OZiva, Plix and Wellbeing Nutrition.

Yes, Pentasure Nutrition is publicly traded on NSE under the ticker symbol HEXAGON.

Pentasure Nutrition operates through Hexagon Nutrition Limited.

The legal entities of Pentasure Nutrition currently have 10 directors, including Vikram Arun Kelkar, Nikhil Arun Kelkar, Keval Mahendra Shah and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available